Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial

By Prof Jianwen Guo et al.

Source The Lancet

Summary
Background There are few proven treatments for acute spontaneous intracerebral haemorrhage, and they all target
reducing expansion of the haematoma. The traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao) in an oral
solution is comprised of several Chinese herbs that are widely used to treat patients with intracerebral haemorrhage
in China on the understanding that they enhance resorption of the haematoma and reduce neuroinflammation. We
aimed to provide a reliable assessment of the safety and efficacy of FYTF-919 in patients with moderate to severe acute
intracerebral haemorrhage.

Read more click here